Neutralization of SARS-CoV-2 Variants by rVSV-ΔG-Spike-Elicited Human Sera

Neutralization of SARS-CoV-2 Variants by rVSV-ΔG-Spike-Elicited Human Sera

The emergence of rapidly spreading variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a major challenge to the ability of vaccines and therapeutic antibodies to provide immunity. These variants contain mutations of specific amino acids that might impede vaccine efficacy....

Full description

Bibliographic Details
Main Authors: Yfat Yahalom-Ronen, Noam Erez, Morly Fisher, Hadas Tamir, Boaz Politi, Hagit Achdout, Sharon Melamed, Itai Glinert, Shay Weiss, Inbar Cohen-Gihon, Ofir Israeli, Marina Izak, Michal Mandelboim, Yoseph Caraco, Noa Madar-Balakirski, Adva Mechaly, Eilat Shinar, Ran Zichel, Daniel Cohen, Adi Beth-Din, Anat Zvi, Hadar Marcus, Tomer Israely, Nir Paran
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Vaccines
Subjects:
COVID-19
SARS-CoV-2
variants
VOC
vaccine
BriLife<sup>®</sup>
Online Access:https://www.mdpi.com/2076-393X/10/2/291

Similar Items

Similar Items